The present application discloses a compound of formula (I): compositions comprising said compound, and a method of using said compound as a cannabinoid receptor ligand in the treatment or prevention of diseases associated with a cannabinoid receptor, such as, CB1, CB2, 5HT1A, 5HT2A, GPR18, GPR119, TRPV1, TPRV2, PPARγ or a μ-opioid receptor.
本申请公开了一种化合物的
化学式(I):包括该化合物的组合物,以及使用该化合物作为
大麻素受体
配体治疗或预防与
大麻素受体相关的疾病的方法,例如CB1、CB2、5HT1A、5HT2A、GPR18、GPR119、TRPV1、TPRV2、
PPARγ或μ-阿片受体。